Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

March 5, 2024 | 9:00 AM - 11:30 AM EDT

Virtual

Overview (Program Summary)

A program hosted by:

ACC Greater Philadelphia

HEALTH, BIOTECH & PHARMA CLE WEBINAR

WEBINAR LINK:

https://accinhouse.zoom.us/j/95607229825
(Same link for both sessions)

 

9:00 a.m. - 10:00 a.m.
"Navigating the Generative AI Landscape in Health Care and Life Sciences"
Presented by Troutman Pepper

This session will delve into the real-world application of artificial intelligence (AI), including generative AI, in health care and life sciences. Our panel will share their journey of implementing generative AI, focusing on the creation and management of AI use policies. Our panelists will shed light on the critical role of legal departments and other key stakeholders in adapting to the evolving regulatory and legal landscape. They will emphasize the importance of clear AI use policies, covering aspects such as patient data privacy, ethical use, and regulatory compliance.

Speakers:

  • Jim Koenig, Partner, Troutman Pepper
  • Dean Forbes, Vice President, Associate General Counsel and Chief Privacy Officer, DaVita
  • Haris Khan, Manager, Corporate Counsel, DaVita
  • Agatha O'Malley, Vice President, Global Privacy Officer, Otsuka Pharmaceutical

 

10:30 a.m. - 11:30 a.m.
"Assessing the Practical Impact of Federal Rule Changes"
Presented by Shook Hardy & Bacon

A roundtable discussion of new and proposed changes to the Federal Rules, including the following specific topics:

First, we will discuss the amendment to Rule 702 regarding admissibility of expert testimony, including recent decisions applying and interpreting the change, and also provide thoughts and guidance as to how it can be used by defense counsel.  

Second, we will discuss the proposed amendments to Rule 16.1 concerning Multi District Litigation procedures.  

Finally, we will provide a preview of the ALI May meeting, noting potential developments that may impact the law surrounding medical monitoring and innovator liability.

Speakers:

  • Adam Tolin, Partner, Shook Hardy & Bacon LLP
  • Mark Behrens, Co-Chair, Public Policy Practice Group, Shook Hardy & Bacon LLP
  • Phil Goldberg, Managing Partner, Shook Hardy & Bacon LLP
  • Deirdre Kole, Assistant General Counsel, Litigation, Johnson & Johnson

 

 


CLE

State: PA & DE (NJ is reciprocal self-reporting)
Category: General
ACC

This site uses cookies to store information on your computer. Some are essential to make our site work properly; others help us improve the user experience.

By using the site, you consent to the placement of these cookies. For more information, read our cookies policy and our privacy policy.

Accept